Author

Hyojin Cho

Chungnam National UniversityORCID 0009-0002-7984-6262Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Hongmei KangiD· 1 shared Hwi-yeol YuniD· 1 shared Hyunjung LeeiD· 1 shared Jae Hyun KimiD· 1 shared Jung‐woo ChaeiD· 1 shared Min‐Gul KimiD· 1 shared Sang-Min ParkiD· 1 shared Sangkeun JungiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Hongmei KangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Model-Driven Hybrid AI Framework for End-to-End Autonomous Decision-Making in Drug Development

Hyunjung Lee, Hongmei Kang, Woojin Jung, Hyojin Cho, Sungwoo Goo, Hwi-yeol Yun, Min‐Gul Kim, Jung‐woo Chae, Sang-Min Park, Soyoung Lee, Jae Hyun Kim, Sangkeun Jung

This paper introduces a hybrid AI framework for drug development that links clinical questions to pharmacokinetic simulations and decision support using PICO specifications and machine learning.

bioRxiv · Feb 6, 2026 · PreprintPharmacology & Toxicology